Purpose of review The outcome of vascularized composite allografts (VCA) often appear unrelated to the presence of donorspecific antibodies (DSA) in blood of the recipient or deposition of complement in the graft. The attenuation of injury and the absence of rejection in other types of grafts despite manifest donor-specific immunity have been explained by accommodation (acquired resistance to immune-mediated injury), adaptation (loss of graft antigen) and/or enhancement (antibody-mediated antigen blockade). Whether and how accommodation, adaptation and/or enhancement impact on the outcome of VCA is unknown. Here we consider how recent observations concerning accommodation in organ transplants might advance understanding and resolve uncertainties about the clinical course of VCA.
INTRODUCTION
Accommodation refers to a condition in which a graft apparently resists acute injury and rejection associated with the presence of donor-specific antibodies (DSA) or other noxious factors in blood [1,2 & ]. Accommodation is one of several conditions, including enhancement, graft adaptation and operational tolerance, characterized by the absence of rejection under conditions in which rejection might be expected to occur (Table 1) . First described in ABO-incompatible kidney transplants and heterotopic cardiac xenografts [3, 4] , accommodation is now recognized to occur in 10-30% of conventional (ABO-compatible) organ transplants [2 & ,5], the frequency varying with the frequency, method and sensitivity of DSA assay used and with donor and recipient characteristics that bear on risk. Whether accommodation occurs in vascularized composite allografts (VCA) and what ultimate impact accommodation might have on outcome is unknown, but the same process has been envisioned to protect tissues in various settings besides organ transplantation [6] [7] [8] 9 && ]. We shall discuss, however, some aspects of accommodation and related conditions that we think could prove relevant understanding of the fate of VCA and possibly advance management of VCA. Although work in experimental VCA provides insights of potential import on this subject, we shall focus on clinical experience and clinical literature for the present communication.
VCAs, like other allografts, are highly immunogenic. In spite of immunosuppression, recent surveys and reviews estimate at least 80% of VCA including skin exhibit at least one episode of rejection, predominantly acute cell mediated rejection (CMR) [10 & ,11,12,13 && -15
The extent of immunogenicity and high frequency of rejection has been ascribed to the presence of allogeneic skin in most VCA, as skin is often considered the most immunogenic tissue (although muscle might be more so) [17] [18] [19] [20] found that 3 years after treatment for severe burns with blood transfusions and in some cases skin allografts, 97% of subjects had anti-HLA antibodies and nearly 2/3 were highly sensitized (defined as PRA >85%), far
KEY POINTS
VCA undergo acute AMR less often than expected given the extensive presensitization of many recipients to allogeneic human leukocyte antigen (HLA; via blood transfusion and skin transplants). In part, this low frequency could reflect repopulation of the graft with recipient blood vessels but it could also reflect processes that protect donor segments in VCA from AMR.
VCAs might undergo less frequent and less severe AMR if antigen shed from the graft suppresses the function of some allospecific B cells (clonal suppression).
The binding of DSA to shed antigen could also hinder development of AMR by blocking alloimmune recognition, a process called enhancement.
The interaction of DSA with the graft could cause loss of antigen by modulation and/or shedding, decreasing the impact of further antibody binding and hence susceptibility to AMR.
The interaction of small amounts of DSA with the graft, perhaps owing to aforementioned mechanisms, could induce changes that make the graft resistance to antibody-mediated injury and hence AMR. . We shall discuss and in Figure 1 we illustrate characteristics of VCA that might limit the incidence and intensity of antibody-mediated injury and AMR.
THE ORIGIN OF THE VASCULAR SUPPLY
One characteristic of grafts that determines susceptibility to rejection is the origin of the vascular supply. The blood vessels of organ grafts derive entirely from the source of the transplant and these are the main targets of DSA in clinical and experimental transplants [2 33] . Antibodies bound to the endothelium in an organ graft activate complement, modifying the physiology of the blood vessels to promote coagulation, inflammation and immunity and to compromise perfusion and vascular integrity and these changes likely underlie the pathology of AMR [7, 34] .
The blood vessels of skin and other tissue transplants, however, derive at least in part from the ingrowth of recipient blood vessels. Recipient blood vessels do not express antigens recognized by DSA and hence might be spared some of the vascular changes observed in AMR. Since 85% of Ig resides in blood, extravascular cells are targeted to a lesser extent than blood vessels and extravascular cells may be less susceptible to complement-mediated pathophysiology [35] . Recipient blood vessels clearly can and do present donor peptide in MHC, which allospecific T cells recognize, infiltrate and trigger CMR. VCAs are also found to contain numerous, possibly expanded populations of donor T cells [16 & ,36,37] . Whether donor-derived T cells attack blood vessels of recipient origin that grow into VCA is unknown, but a question of potential import since donor T cells presumably are less subject to control by induction regimens.
Reports describing deposits of C4d [18,26 && , 38-40] might be taken as evidence that VCA contain more donor endothelium than conventional tissue transplants and hence might be subject to DSAinduced injury and rejection. However, activation of C4 and hence deposition of C4d does not necessarily depend on binding of DSA. In ischemic tissues C4d deposits might be generated by binding of autoantibodies [41, 42] or by recruitment of the lectin complement pathway [43] . For these reasons, and others [44, 45] the presence of C4d cannot be taken as proof of binding of DSA to donor capillaries in VCA susceptibility to DSA-mediated injury. However, VCA could and probably do have a considerable fraction of donor endothelium because the surgical anastomosis and distance from a source of recipient blood vessels may limit neo-vascularization. Why these segments are so infrequently injured by DSA and how exactly the susceptibility to and pathogenesis of rejection of VCA departs from those of organ grafts or 'conventional' tissue grafts is clearly unknown. We will discuss accommodation and related conditions as potential explanations. . However, binding of DSA to shed antigen could decrease levels of DSA detected in conventional assays. Adaptation (i.e. decreased absorption to the graft) might also explain in part the association sometimes observed between DSA in blood and chronic graft changes, the greater tendency for DSA to be associated with AMR early after transplantation and the resolution of AMR without sequelae. On the other hand, for reasons given above, one should not assume that presence of C4d in VCA excludes adaptation, as ischemia and injury could recruit autoantibodies and/or trigger the lectin pathway of complement.
CONDITIONS THAT EXPLAIN ABSENCE OF REJECTION OF TRANSPLANTS
Enhancement was originally recognized as an improvement in the survival and growth of tumor allografts caused by DSA. Enhancement of skin grafts and organs grafts has been reported but the preponderance of work has been conducted in tumor systems [2 & ,47] . Enhancement is thought to occur when DSA blocks immune recognition of tumor cells, decreasing alloimmune responses. Nearly all work on enhancement has focused on putative DSA-induced suppression of cell-mediated immunity and hence CMR and a relationship to DSA production and protection against AMR has not been explored. Recent investigation of ABO-incompatible kidney transplants, however, suggests that interaction of antiblood group antibodies with the grafts can liberate antigen and antigen so released from grafts might suppress further production of antibody against donor blood groups [52 & ]. At first glance, the observation might be thought to exemplify spontaneous tolerance observed in young heart transplant recipients [53] . However, expression of blood group antigens was decreased, suggesting as one possibility that small amounts of DSA caused the antigen to be shed and the mobilized antigen in turn could have suppressed the function of some donor-specific B cells. Antigen-induced suppression of B cells via anergy or deletion has been known for decades [54] , but the pertinence of such clonal suppression for transplantation has not been explored (perhaps because mobilization of blood group saccharides spares the epitopes while mobilization of MHC might not). The greater extent of tissue disruption in VCA, however, might bring cause shedding of sufficient amounts of native antigen to enable this mechanism to be manifested. Whether such impact of shed antigen as it occurs is best termed clonal suppression or adaptation or enhancement is not clear. Regardless, the process could also allow accommodation to ensue, as discussed in the following.
Manipulation of cell surfaces can also impact on DSA interaction with HLA. Treatment of endothelial cells with antiblood group antibodies was recently shown also to decrease expression of HLA-DR leading to decreased susceptibility to complementmediated cytotoxicity induced by anti-HLA-DR antibodies [55] , a finding consistent with adaptation. As blood group antigens are expressed as modifications of various cell membrane proteins and neutral lipids, it is impossible to know whether the impact of the antibodies is specific for one or another core structure or a general phenomenon. However, we imagine that lectins might be used to target blood group O, A or B in endothelial cells of a VCA to a similar effect, as Dalmasso et al. [56] first showed in a nonhuman system. Accommodation is defined as acquired resistance to immune and especially antibody-and complement-mediated injury [2 & , 57, 58 & ]. In organ transplants, accommodation is typically recognized when the presence of DSA in blood was not paralleled by rejection. Although accommodation is readily detected in ABO-incompatible organ transplants [59] it is more difficult to appreciate in ABOcompatible transplants [44, 46] . Accommodation can be difficult to detect because normal organs have the capacity to absorb large amounts of antibody, depleting much or all DSA from blood. Conversely, organs injured by immune or nonimmune processes can absorb fewer antibodies. Hence, the levels of DSA in blood are often found to increase after rejection rather than before [60] . For this reason, we have proposed that technologies directed at detecting donor-specific B cell responses might offer keen insights into alloimmunity and accommodation [46] .
MECHANISMS, INCEPTION AND OUTCOME OF ACCOMMODATION
Accommodation is generally believed to reflect changes in graft endothelial cells and possibly other cells that impart resistance to cytotoxicity [61] [62] [63] [64] . The postulated mechanisms have been reviewed [1] and we shall not consider that subject since the pertinence for VCA remains to be established. Instead, we consider characteristics of VCA that could favor development of accommodation and related conditions over rejection (Fig. 1) .
One pertinent consideration for VCA is the interpretation given to the presence of C4d in tissues. More important than the question of whether presence of C4d reflects binding of DSA or autoantibodies or activation of the lectin pathway, as discussed above, might be the question of whether C4d necessarily reflects past or present tissue injury. We observe C4 activation and C4d deposition in accommodation when significant injury is absent [7] and that is consistent with reports on the apparent absence of rejection in some VCA More to this point is that C4d is catalytically inert and if anything protective -the amino or hydroxyl groups covalently bound to C4d being unavailable as targets for activated C4 or C3 limits ongoing complement-mediated injury.
Our original concept that low levels of DSA induce accommodation while high levels of DSA induce rejection has been repeatedly affirmed both in ABO-incompatible and in conventional transplants. However, the relationship between DSA level and accommodation in organ transplants does always hold over time, suggesting induction and maintenance of accommodation have distinct requirements or that factors that induce accommodation differ from factors that maintain accommodation. The greater extent of tissue disruption in VCA compared to organ transplants might generate more soluble (or suspended) donor HLA, which by hindering the binding of DSA and/or consuming complement, or in some instances by suppressing the further production of DSA [55] might allow the physiology of low DSA concentrations to prevail. Consistent with that possibility is the rarity of hyperacute rejection in VCA.
Another factor of potential importance is the nature of antibodies that bind to the graft. We have discussed the possibility that some antibodies, including some DSA, might be 'protective,' especially at lower concentrations [65 & ]. These antibodies, which are autoreactive and bind especially to ischemic or injured cells, might induce accommodation as originally defined or promote repair. In either case, a VCA recipient might be disadvantaged by nonspecific removal of Ig.
We have thought for some time that our original concept of accommodation as simply resistance to immune-mediated injury was overly simplistic. We reasoned that the changes that protect tissues and organs must have dysphysiologic consequences or they would be constitutive rather than induced [8, 66, 67] . These consequences could include the pathologic changes of chronic rejection. If our concerns prove justified, then efforts directed at understanding accommodation and related conditions might offer new avenues for averting some of the chronic problems that plague VCA.
CONCLUSION
The procedures associated with transplantation of composite tissues and the manner by which VCA are vascularized establish conditions that potentially accentuate enhancement, adaptation and accommodation. These conditions include the shedding and modulation of alloantigen, exchange of recipient for host endothelial cells, blocking of antigen recognition and acquired resistance of the graft to injury induced by DSA. The combination of enhancement, adaptation and accommodation might explain why the presence of DSA in blood and especially the deposition of complement might induce less acute injury than expected. However, protection of the graft might also engender a biological cost manifest as chronic pathologic. Although aimed at reviewing recent literature, this article broadly and critically discusses some technologies that could be applied to detecting and weighing the significance of donor-specific immune responses to VCA. The article is notable for mention of donor-specific B cell responses, discussed more completely in [46] . Presence of vascularized bone with VCA has been postulated to constrain alloimmune responses and hence rejection. This letter reports that bone marrow per se does not decrease the frequency and severity of rejection in VCA in a nonhuman primate model. The authors conclude that bone marrow per se does not modify immunity; however, the findings also invite inquiry about whether vascularized bone and isolated bone marrow cells have disparate impact on accommodation and related conditions in VCA.
